Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
23WELL, THE health supplement brand on the watch 2024-04-02 09:07
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification 2024-04-01 21:00
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones 2024-04-01 21:00
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development 2024-04-01 20:00
Hyosung TNC Invests $1 Billion in Future "Bio" Business 2024-04-01 08:18
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade 2024-03-29 06:00
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future 2024-03-28 22:46
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development 2024-03-27 20:00
Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project 2024-03-27 11:24
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology 2024-03-27 06:00
Keymed Biosciences Announces 2023 Annual Results and Business Updates 2024-03-27 01:16
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition 2024-03-26 20:00
Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa 2024-03-26 19:00
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results and a Special Cash Dividend 2024-03-26 18:00
Cicada Innovations launches HealthTech Hub in Western Sydney's "hidden innovation ecosystem" 2024-03-26 10:00
BioDuro-Sundia's Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167 2024-03-26 08:30
WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones 2024-03-25 21:39
Veeva Vault EDC Surpasses 1,000 Study Start Milestone 2024-03-25 08:00
1 4 5 6 7 8 150